Company Profile

Plantvax Inc (AKA: Plant Vax Inc)
Profile last edited on: 4/30/2018      CAGE: 4UYJ7      UEI: G2LENL4JLTA5

Business Identifier: Plant derived enzymes for use in medical and scientific research
Year Founded
2007
First Award
2007
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9430 Key West Avenue #120
Rockville, MD 20850
   (240) 453-6247
   info@plantvax.com
   www.plantvax.com
Location: Single
Congr. District: 08
County: Montgomery

Public Profile

PlantVax is developing recombinant therapeutic proteins in plant and mammalian expression systems. The focus of the research is production of highly neutralizing HIV mAbs to use as passive immunotherapeutics to prevent HIV transmission or infections and the production of an organophosphate bioscavenger pretreatment to prevent neurotoxicity resulting from nerve agent or pesticide exposure. PlantVax was founded to develop and commercialize discoveries made for the pre- and post-exposure treatments for nerve agent exposure and the treatment, diagnosis and control of global infectious diseases of which HIV is the initial target.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Key People / Management

  Yvonne J Rosenberg -- President

Company News

There are no news available.